Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 12 citations · 50 references
MedicineCancer BiologyOncologyMolecular OncologyOncogenesTumor ProgressionCancer BiomarkersCancer Cell SignalingCancer Survival AnalysisMolecular Tumor ProfilingOncogenic Signaling PathwaysExtracellular Signal-regulated Kinase PathwayMapk SignalingPhosphatidylinositol 3-Kinase PathwayPhosphatidylinositol 3-Kinase-akt PathwayPhosphatidylinositol 3-Kinase-akt SignalingPi3 Kinase-akt SignalingPi3k-akt Signaling PathwayPrognostic Factors Analysis
Acute myeloid leukemia (AML) is a malignant hematopoietic disease with poor clinical course and outcome. There is a constant need for new prognostic factors that could facilitate patient risk stratification. The aim of our research was to determine the phosphorylation levels of phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) pathways in leukemic cells, their relation to P-glycoprotein (P-gp) expression/activity and their prognostic significance in adult de novo AML. A total of 118 patients with AML were enrolled in the study. In a multivariate Cox regression analysis we found that P-gp activity and Akt phosphorylation were independent poor prognostic factors of overall survival (OS). In contrast, phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) represented a favorable prognostic factor of OS and relapse-free survival (RFS). A negative correlation between P-gp activity and p38 phosphorylation level was found, implying a possible role of this MAPK pathway in P-gp regulation. In addition, we found correlation between Akt and p38 phosphorylation levels, indicative of co-activation of two signaling cascades in AML.
50
A RAPID BANDING TECHNIQUE FOR HUMAN CHROMOSOMES
M. Seabright · The Lancet · 1971 · 5K citations
John M. Hoenig, Dennis M. Heisey · The American Statistician · 2001 · 1.9K citations
Christian Thiede, Christine Steudel, Brigitte Mohr et al. · Blood · 2002 · 1.7K citations · Full text
Medicine, Genetics, Hematology +14